- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 211/38 - Atomes d'halogènes ou radicaux nitro
Détention brevets de la classe C07D 211/38
Brevets de cette classe: 198
Historique des publications depuis 10 ans
|
9
|
13
|
14
|
14
|
6
|
15
|
9
|
11
|
14
|
10
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Alkermes Pharma Ireland Limited | 260 |
9 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 850 |
8 |
| 3m Innovative Properties Company | 17717 |
7 |
| Vividion Therapeutics, Inc. | 40 |
5 |
| Theravance Biopharma R&D IP, LLC | 453 |
4 |
| Boehringer Ingelheim International GmbH | 4626 |
3 |
| Janssen Pharmaceutica N.V. | 3357 |
3 |
| Massachusetts Institute of Technology | 10161 |
3 |
| California Institute of Technology | 4000 |
3 |
| Toray Industries, Inc. | 7021 |
3 |
| National Institute of Advanced Industrial Science and Technology | 3798 |
3 |
| The Broad Institute, Inc. | 1879 |
3 |
| ChemoCentryx, Inc. | 379 |
3 |
| Jiangsu Kanion Pharmaceutical Co., Ltd. | 84 |
3 |
| OPKO Health, Inc. | 45 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 866 |
3 |
| Teijin Pharma Limited | 256 |
3 |
| Teika Pharmaceutical Co., Ltd. | 34 |
3 |
| Toyama Chemical Co., Ltd. | 99 |
3 |
| Toyama Prefectural University | 27 |
3 |
| Autres propriétaires | 120 |